Incyte Corp. (INCY)
127.75
-0.37
(-0.29%)
USD |
NASDAQ |
Aug 27, 16:00
127.62
-0.13
(-0.10%)
After-Hours: 18:20
Incyte 1 Year Total Returns (Daily) : 52.52% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | 52.52% |
| August 25, 2026 | 53.04% |
| August 24, 2026 | 50.49% |
| August 21, 2026 | 47.71% |
| August 20, 2026 | 47.59% |
| August 19, 2026 | 50.33% |
| August 18, 2026 | 45.40% |
| August 17, 2026 | 42.08% |
| August 14, 2026 | 39.46% |
| August 13, 2026 | 40.38% |
| August 12, 2026 | 47.98% |
| August 11, 2026 | 52.89% |
| August 10, 2026 | 55.06% |
| August 07, 2026 | 54.17% |
| August 06, 2026 | 52.45% |
| August 05, 2026 | 54.13% |
| August 04, 2026 | 54.54% |
| August 03, 2026 | 56.67% |
| July 31, 2026 | 59.59% |
| July 30, 2026 | 58.59% |
| July 29, 2026 | 64.26% |
| July 28, 2026 | 85.19% |
| July 27, 2026 | 69.33% |
| July 24, 2026 | 66.93% |
| July 23, 2026 | 65.07% |
| Date | Value |
|---|---|
| July 22, 2026 | 68.06% |
| July 21, 2026 | 74.22% |
| July 20, 2026 | 70.42% |
| July 17, 2026 | 70.08% |
| July 16, 2026 | 68.50% |
| July 15, 2026 | 68.63% |
| July 14, 2026 | 64.16% |
| July 13, 2026 | 66.54% |
| July 10, 2026 | 65.92% |
| July 09, 2026 | 72.47% |
| July 08, 2026 | 73.28% |
| July 07, 2026 | 75.49% |
| July 06, 2026 | 68.91% |
| July 02, 2026 | 71.42% |
| July 01, 2026 | 65.59% |
| June 30, 2026 | 66.46% |
| June 29, 2026 | 67.71% |
| June 26, 2026 | 60.64% |
| June 25, 2026 | 59.19% |
| June 24, 2026 | 57.17% |
| June 23, 2026 | 55.22% |
| June 22, 2026 | 51.42% |
| June 18, 2026 | 43.87% |
| June 17, 2026 | 43.86% |
| June 16, 2026 | 40.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Mirum Pharmaceuticals, Inc. | 32.76% |
| Regeneron Pharmaceuticals, Inc. | 39.35% |
| BioMarin Pharmaceutical, Inc. | 14.20% |
| Eli Lilly & Co. | 62.62% |
| Biogen, Inc. | 61.70% |